Vanguard Capital Wealth Advisors Moderna, Inc. Transaction History

Vanguard Capital Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$117.13 - $176.59 $291,068 - $438,826	-2,485 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$126.46 - $235.05 $205,497 - $381,956	1,625 Added 188.95%	2,485 $428,000
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $5,645 - $9,212	25 Added 2.99%	860 $218,000
Q3 2021 Nov 01, 2021	BUY	$221.9 - $484.47 $185,286 - $404,532	835 New	835 $322,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.